Latest On Abacus Health Products, Inc (ABAHF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-12-04 06:39 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-27 01:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 21:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 01:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 15:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-03 07:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 07:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 03:51 EST | News | Abacus Health Products Inc (ABAHF) CEO Perry Antelman on Q4 2019 Results - Earnings Call Transcript | N/A | |
| 2020-06-25 03:47 EST | News | Abacus Health Products misses on revenue | N/A | |
About Abacus Health Products, Inc (ABAHF):
Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemps. The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain, which includes analgesic ointments, creams, and pain sticks, as well as analgesic massage oils. It provides CBDMEDIC line of products, such as active sport ointments and pain sticks, back and neck ointments, arthritis hand creams and ointments, and massage therapy oils, as well as ointments and pain sprays for muscles and joints. The company also offers CBDMEDIC line of therapeutic skincare products, such as medicated ointment for itches, rashes, and eczema; medicated cream for acne treatment; and foaming facial cleanser. Further, it provides Harmony Hemp products, including HempBath, NeuroComfort, and Flexible for personal skincare and OTC topicals through grocery chains. In addition, the company offers its CBD CLINIC products to registered health practitioners, including chiropractors, acupuncturists, massage and physical therapists, naturopaths, and osteopaths; and CBDMEDIC products directly to consumers through retail pharmacy chains and fitness locations, as well as online through the e-commerce platform. In addition, it is involved in developing a pipeline of other CBD products addressing additional medical indications and the health and wellness sectors. The company is headquartered in Toronto, Canada. As of June 11, 2020, Abacus Health Products, Inc. operates as a subsidiary of Charlotte's Web Holdings, Inc.
General
- Name Abacus Health Products, Inc
- Symbol ABAHF
- Type Common Stock
- Exchange OTCQB
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 57
- Fiscal Year EndDecember
- Web URLhttp://abacushp.com
Valuation
- Price/Sales (Trailing 12 Mt.) 7.27
- Price/Book (Most Recent Quarter) 3.11
- Enterprise Value Revenue 5.56
Financials
- Most Recent Quarter 2020-03-31
- Profit Margin -41%
- Operating Margin -119%
- Return on Assets -39%
- Return on Equity -33%
- Revenue 15.77 million
- Earnings Per Share -$0.64
- Revenue Per Share $0.75
- Gross Profit 8.47 million
- Quarterly Earnings Growth 6.5%
Highlights
- Market Capitalization 104.6 million
- EBITDA -6328835
- Book Value Per Share $1.56
Share Statistics
- Shares Outstanding 11.99 million
- Shares Float 19.98 million
- % Held by Insiders 76%
- % Held by Institutions 3.92%
Technicals
- 52 Week High $5.77
- 52 Week Low $2
- 50 Day Moving Average 5
- 200 Day Moving Average 3.59
Dividends
- Dividend Date N/A
- ExDividend Date N/A
Abacus Health Products, Inc (ABAHF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Abacus Health Products, Inc (ABAHF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-03-31 | $4.07 million | -$0.11 | ||
| 2019-12-31 | 2019-12-31 | $4.4 million | -$0.22 | ||
| 2019-09-30 | 2019-09-30 | $4.07 million | $0.00 | ||
| 2019-06-30 | 2019-06-30 | $3.22 million | $0.02 | ||
| 2019-03-31 | 2019-03-31 | $3.82 million | -$0.79 |
Abacus Health Products, Inc (ABAHF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Research Development | 95350 | 59396 | 62567 | 98347 | 360045 |
| Income Before Tax | -3.44 million | -4.93 million | -2.2 million | -571417 | -13.27 million |
| Selling General Administrative | 6.17 million | 7.27 million | 7.59 million | 5.28 million | 4.76 million |
| Gross Profit | 2.09 million | 1.62 million | 2.45 million | 1.98 million | 2.42 million |
| Ebit | -3.28 million | -4.75 million | -2.07 million | -3.46 million | -13.05 million |
| Operating Income | -4.27 million | -5.78 million | -5.27 million | -3.46 million | -2.72 million |
| Income Tax Expense | -1.11 million | -403335 | -2.21 million | -1.01 million | -730656 |
| Total Revenue | 4.07 million | 4.4 million | 4.07 million | 3.22 million | 3.82 million |
| Cost of Revenue | 1.98 million | 2.78 million | 1.62 million | 1.25 million | 1.4 million |
| Total Other Income Expense Net | 859838 | 886538 | 3.01 million | 2.89 million | -10.35 million |
| Net Income From Continuing Operations | -2.33 million | -4.53 million | 6656 | 439082 | -12.54 million |
| Net Income Applicable to Common Shares | -2.33 million | -4.53 million | 6656 | 439082 | -12.54 million |
Cash Flow:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Investments | -1 million | -483804 | -20137 | N/A | -142501 |
| Change to Liabilities | -524054 | -1.86 million | 1.19 million | -396270 | 1.72 million |
| Total Cash Flow from Investing Activities | -1 million | -483804 | -20137 | -211447 | -142501 |
| Net Borrowings | -46406 | -45211 | -45019 | -36446 | -15426 |
| Total Cash Flow from Financial Activities | -46406 | -45211 | -23655 | 24.88 million | 14.74 million |
| Change to Operating Activities | 231701 | -982263 | -371287 | -761434 | 350107 |
| Change in Cash | -4.93 million | -6.05 million | -4.03 million | 19.38 million | 9.07 million |
| Total Cash from Operating Activities | -3.88 million | -5.52 million | -3.99 million | -5.28 million | -5.53 million |
| Depreciation | 100475 | 76223 | 72913 | 57372 | 24804 |
| Other Cash Flow from Investing Activities | -437225 | -451497 | 36802 | -4746 | -4575 |
| Change to Inventory | -28370 | 665332 | 2.21 million | -232511 | -3.14 million |
| Change to Account Receivables | -138656 | -965849 | -10589 | -592113 | -1.21 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | -1.19 million | -364053 | -4.74 million | -3.8 million | 9.4 million |
| Capital Expenditures | 54705 | 32307 | 56939 | 206701 | 137926 |
Balance Sheet:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 5.31 million | 4.62 million | 7.29 million | 9.22 million | 16.19 million |
| Total Stockholder Equity | 33.63 million | 32.55 million | 36.3 million | 34.22 million | 4.99 million |
| Other Current Liabilities | 504024 | 1.34 million | 2.11 million | 5.19 million | 9.24 million |
| Total Assets | 38.94 million | 37.16 million | 43.58 million | 43.44 million | 21.18 million |
| Common Stock | 46.57 million | 46.57 million | 46.57 million | 44.92 million | 17.81 million |
| Other Current Assets | 604094 | N/A | 2.34 million | N/A | N/A |
| Retained Earnings | -20.48 million | -18.15 million | -13.62 million | -13.63 million | -14.06 million |
| Other Liabilities | 361613 | N/A | N/A | N/A | N/A |
| Other Assets | 8.32 million | 6.88 million | 6.06 million | 1.87 million | 851579 |
| Cash | 17.26 million | 22.19 million | 28.24 million | 32.27 million | 12.89 million |
| Total Current Liabilities | 4.76 million | 4.37 million | 7 million | 8.89 million | 13.57 million |
| Other Stockholder Equity | -43750 | -24205 | 85746 | 33818 | 21185 |
| Property, Plant & Equipment | 820915 | 843163 | 869894 | 886570 | 613521 |
| Total Current Assets | 25.39 million | 29.44 million | 36.65 million | 40.68 million | 19.71 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 29.21 million | 32.55 million | 36.3 million | 34.22 million | 4.99 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | 2.34 million |
| Inventory | 2.22 million | 1.5 million | 2.16 million | 4.37 million | 4.14 million |
| Accounts Payable | 2.32 million | 2.84 million | 4.7 million | 3.51 million | 3.91 million |
Abacus Health Products, Inc (ABAHF) Chart:
Abacus Health Products, Inc (ABAHF) News:
Below you will find a list of latest news for Abacus Health Products, Inc (ABAHF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Abacus Health Products, Inc (ABAHF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Abacus Health Products, Inc (ABAHF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|